Under construction – not a live service
Sign in
Taking peopleNo phase

AI-Assisted Colonoscopy Scoring for Ulcerative Colitis Activity

Studies a simpler colon scoring method using imaging and AI in adults with ulcerative colitis.

Key facts

Who runs it
University College Cork
Where
Singapore, SingaporeSee the siteAlso in 5 other countries, 10 sites
Trial code
Registry title
AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
Status
Recruiting
People taking part
300 people, planned
Started
4 Nov 2024
Expected to end
30 Sept 2027
Type of study
Observational
Treatments tested
  • Colonoscopy after bowel cleansing
  • Intestinal biopsies
  • blood sampling
  • Stool
  • Clinical follow-up
Record updated
3 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 75 who have had ulcerative colitis for at least six months and are having an endoscopy to check disease activity or for cancer surveillance.

Age
18 to 75 years
Sex
All sexes can join.
Disease stage
Ulcerative colitis (UC) diagnosed at least six months ago, whatever the current treatment.
Earlier treatment
No specific treatment is required. Anyone in a recent experimental trial must have finished it at least thirty days before this study.

Main reasons for not taking part

  • Cannot have endoscopy or biopsies safely (for example toxic megacolon, severe coagulopathy or thrombocytopenia)
  • Poor bowel preparation (total BBPS <6, or BBPS <2 in the segment seen for sigmoidoscopy)
  • Other serious illness that limits life expectancy or makes endoscopy high risk
  • Pregnant or breast-feeding
  • Unable to give informed consent

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult patients aged 18 to 75 years old
  • Established diagnosis of UC (for at least six months in duration), independently from their active treatment
  • Undergoing endoscopy for disease activity assessment or cancer surveillance

Who cannot take part

  • If the participant has been in a recent experimental trial, these must have been completed not less than thirty days prior to this study
  • Contraindications to endoscopy (including toxic megacolon) and biopsies (including severe coagulopathy/thrombocytopenia)
  • Poor bowel preparation (defined as total BBPS <6 or BBPS <2 in observed segment for sigmoidoscopy)
  • Significant co-morbidities limiting life expectancy and conferring high risk of endoscopy
  • Pregnant and breast-feeding subjects
  • Inability to provide informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in Singapore

Also in 5 other countries, 10 sites

  • Changi General HospitalSingapore, SingaporeContact: Kimg Tan ChinNot yet recruiting

About the trial

What the trial wants to find out

This international multicentre prospective study aims to develop a new simple score using enhanced endoscopic techniques which focus on the vascular features of the colon and reliably distinguish between a quiescent and a mild inflammation in ulcerative colitis (UC). The diagnostic performance of the new score in defining disease activity/remission compared to existing endoscopic and histological scores and predict long-term clinical outcomes will be evaluated. The study also aims to adapt current artificial intelligence (AI) algorithms for enhanced endoscopic techniques to improve standardization in UC disease assessment and outcome prediction.

The group in the trial

  • Ulcerative Colitis patients

    UC patients who have been scheduled for colonoscopy for disease assessment or surveillance

    Treatment: Colonoscopy after bowel cleansing, Intestinal biopsies, blood sampling, Stool, and Clinical follow-up

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Novel Simplified Endoscopic Score aiMed at Evaluating Ulcerative cOlitis Activity Through TXI, RDI and NBI Vascular Assessment and at prEdicting Clinical Outcome and Its Applicability in an arTificial Intelligence System: the MONET Study
Plain-language title
AI-Assisted Colonoscopy Scoring for Ulcerative Colitis ActivityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06709209, who can take part
Record updated
3 December 2024